
|Articles|August 4, 2020
Raremark launches Xperiome Platform
Advertisement
Raremark has launched its patient-powered knowledge platform Xperiome. The Xperiome platform expands on Raremark’s vision of a world in which all rare diseases are treated by connecting everyone affected by rare diseases through shared experiences—regardless of diagnosis.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective
3
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
4
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
5




